EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin

Annie Moradian, Elisha Goonatilleke, Tai-Tu Lin, Maya Hatten-Beck, Michelle Emrick, Athena A Schepmoes, Thomas L Fillmore, Michael J MacCoss, Salvatore Sechi, Kimia Sobhani, Randie Little, Kuanysh Kabytaev und 3 weitere

Clinical Chemistry · 03.06.2024 · 70 (6) · 855-864

DOI: 10.1093/clinchem/hvae034 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Chemistry, online erschienen am 29.03.2024. Verfasst von Annie Moradian und 14 weiteren Autor:innen. Beteiligte Einrichtung: Precision Biomarker Laboratories, Cedars-Sinai Medical Center, Los Angeles, CA, United States. Hauptthemen laut MEDLINE: C-Peptide, Tandem Mass Spectrometry, Insulin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The enhanced precision and selectivity of liquid chromatography–tandem mass spectrometry (LC-MS/MS) makes it an attractive alternative to certain clinical immunoassays. Easily transferrable work flows could help facilitate harmonization and ensure high-quality patient care. We aimed to evaluate the interlaboratory comparability of antibody-free multiplexed insulin and C-peptide LC-MS/MS measurements.

Methods

The laboratories that comprise the Targeted Mass Spectrometry Assays for Diabetes and Obesity Research (TaMADOR) consortium verified the performance of a validated peptide-based assay (reproducibility, linearity, and lower limit of the measuring interval [LLMI]). An interlaboratory comparison study was then performed using shared calibrators, de-identified leftover laboratory samples, and reference materials.

Results

During verification, the measurements were precise (2.7% to 3.7%CV), linear (4 to 15 ng/mL for C-peptide and 2 to 14 ng/mL for insulin), and sensitive (LLMI of 0.04 to 0.10 ng/mL for C-peptide and 0.03 ng/mL for insulin). Median imprecision across the 3 laboratories was 13.4% (inter-quartile range [IQR] 11.6%) for C-peptide and 22.2% (IQR 20.9%) for insulin using individual measurements, and 10.8% (IQR 8.7%) and 15.3% (IQR 14.9%) for C-peptide and insulin, respectively, when replicate measurements were averaged. Method comparison with the University of Missouri reference method for C-peptide demonstrated a robust linear correlation with a slope of 1.044 and r2 = 0.99.

Conclusions

Our results suggest that combined LC-MS/MS measurements of C-peptide and insulin are robust and adaptable and that standardization with a reference measurement procedure could allow accurate and precise measurements across sites, which could be important to diabetes research and help patient care in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-PeptideTandem Mass SpectrometryInsulinHumansChromatography, LiquidReproducibility of ResultsLaboratoriesLiquid Chromatography-Mass Spectrometry

Substanzen

C-PeptideInsulin

Autor:innen und Institutionen

  • Precision Biomarker Laboratories, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
  • Integrative Omics, Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.
  • Department of Genome Sciences, University of Washington, Seattle, WA, United States.
  • Division of Diabetes, Endocrinology, & Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.
  • Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

ORCID-Profile: Wei-Jun Qian, Andrew N Hoofnagle

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Moradian, A., Goonatilleke, E., Lin, T. T., Hatten-Beck, M., Emrick, M., Schepmoes, A. A., Fillmore, T. L., MacCoss, M. J., Sechi, S., Sobhani, K., Little, R., Kabytaev, K., van Eyk, J. E., Qian, W. J., & Hoofnagle, A. N. (2024). Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin. Clinical Chemistry, 70(6), 855-864. https://doi.org/10.1093/clinchem/hvae034

Vancouver

Moradian A, Goonatilleke E, Lin TT, Hatten-Beck M, Emrick M, Schepmoes AA, et al. Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin. Clinical Chemistry. 2024;70(6):855-864. doi:10.1093/clinchem/hvae034

BibTeX
@article{Moradian2024,
  author = {Moradian, Annie and Goonatilleke, Elisha and Lin, Tai-Tu and Hatten-Beck, Maya and Emrick, Michelle and Schepmoes, Athena A and Fillmore, Thomas L and MacCoss, Michael J and Sechi, Salvatore and Sobhani, Kimia and Little, Randie and Kabytaev, Kuanysh and van Eyk, Jennifer E and Qian, Wei-Jun and Hoofnagle, Andrew N},
  title = {Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin},
  journal = {Clinical Chemistry},
  year = {2024},
  volume = {70},
  number = {6},
  pages = {855--864},
  doi = {10.1093/clinchem/hvae034}
}
Kostenlos starten →